These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30775350)

  • 1. Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus.
    Jo YM; Kim J; Chang J
    Clin Exp Vaccine Res; 2019 Jan; 8(1):43-53. PubMed ID: 30775350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
    Lee JY; Chang J
    J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease.
    Kim S; Chang J
    Immune Netw; 2012 Feb; 12(1):8-17. PubMed ID: 22536165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
    Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
    Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
    Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
    Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
    J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.
    Zeng R; Zhang H; Hai Y; Cui Y; Wei L; Li N; Liu J; Li C; Liu Y
    J Virol; 2012 Apr; 86(8):4505-17. PubMed ID: 22301139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.
    Li N; Zhang L; Zheng B; Li W; Liu J; Zhang H; Zeng R
    Hum Vaccin Immunother; 2019; 15(11):2684-2694. PubMed ID: 31021703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).
    Cheon IS; Shim BS; Park SM; Choi Y; Jang JE; Jung DI; Kim JO; Chang J; Yun CH; Song MK
    PLoS One; 2014; 9(4):e94269. PubMed ID: 24736750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant.
    Kim S; Joo DH; Lee JB; Shim BS; Cheon IS; Jang JE; Song HH; Kim KH; Song MK; Chang J
    PLoS One; 2012; 7(2):e32226. PubMed ID: 22384186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus.
    Park MH; Chang J
    Immune Netw; 2012 Dec; 12(6):261-8. PubMed ID: 23396871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection.
    Zhang Y; Qiao L; Hu X; Zhao K; Zhang Y; Chai F; Pan Z
    Vaccine; 2016 Jan; 34(2):252-260. PubMed ID: 26643933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice.
    Cai M; Wang C; Li Y; Gu H; Sun S; Duan Y; Lai C; Wang K; Yang X; Xing L; Zhang P; Wang Z; Zhang S; Guo X; Liu S; Tong Y; Wang X; Yang P
    Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):74-82. PubMed ID: 27974288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus.
    Hu B; Jiang J; Zhan J; Li G; Jiang Y; Guan X; Chen Y; Fang Z
    Virol J; 2014 Aug; 11():142. PubMed ID: 25107552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice.
    Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zheng YP; Hong T; He JS
    Immunol Lett; 2016 Nov; 179():95-101. PubMed ID: 27688078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.